Investor Day 2024
Logotype for Evolus Inc

Evolus (EOLS) Investor Day 2024 summary

Event summary combining transcript, slides, and related documents.

Logotype for Evolus Inc

Investor Day 2024 summary

8 Jul, 2026

Strategic vision and market positioning

  • Transitioning from medical aesthetics/pharma to a broader beauty focus, targeting millennials and the $1.5T beauty and wellness market, integrating injectables into mainstream beauty regimens.

  • Positioned as a performance beauty company, leveraging a cash pay model, design-centric innovation, and digital infrastructure for differentiation.

  • Achieved 13% U.S. market share in five years, with Jeuveau as the fastest-growing brand and #2 in consumer awareness.

  • Expanding global reach into seven key markets, aiming for $100 million in international revenue by 2028.

  • Strong brand identity and consumer-centric approach, with high satisfaction and awareness among millennials and industry recognition.

Product innovation and clinical differentiation

  • Jeuveau demonstrated superior or comparable efficacy to market leaders in head-to-head Phase III trials, with faster onset and longer duration.

  • Evolysse, a next-generation HA filler using Cold Technology, showed statistical superiority and efficiency in clinical trials, with less volume needed for better results.

  • Launch of Form and Smooth fillers in the U.S. within 12 months, covering 95% of HA procedures, with Sculpt and Lips to follow through 2027.

  • Product launches sequenced with additional indications planned through 2027 and beyond.

  • High product satisfaction and versatility highlighted by independent clinical investigators and practitioners.

Digital platform and customer engagement

  • Proprietary digital platform enables seamless ordering, practice management, and patient loyalty programs.

  • Co-branded media campaigns and hyper-localized marketing drive practice growth and brand awareness, with 1.5 billion impressions delivered.

  • Evolus Rewards, a text-based loyalty program, is on track for one million enrollments by year-end, supporting high patient retention.

  • Club Evolus, a new patient membership program, offers affordable, recurring treatments and is set for national launch.

  • Digital infrastructure supports scalability and integration of new products, enhancing customer and consumer experience.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more